Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID-19 mRNA vaccine booster study
NCT05960097Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2023
- Primary completion
- Aug 2024
- Modality
- Vaccines & Immunotherapeutics, Lipid-based Nanoparticles, mRNA Therapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of CV0701, CV0601, CV0801 in coronavirus disease 2019 (COVID-19), sponsored by GSK. Started Aug 2023; status: completed.
02
Drugs
CV0701CV0601CV0801
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05960097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05960097.